| scholarly article | Q13442814 |
| P50 | author | C. Ronald Kahn | Q16106681 |
| Christopher B Newgard | Q87867408 | ||
| P2093 | author name string | David E Cohen | |
| Shiho Fujisaka | |||
| Olga Ilkayeva | |||
| Kevin Fitzgerald | |||
| Samir Softic | |||
| Tata Nageswara Rao | |||
| Brian T O'Neill | |||
| Carole Harbison | |||
| Guo-Xiao Wang | |||
| Jennifer Willoughby | |||
| Manoj K Gupta | |||
| P2860 | cites work | Health implications of fructose consumption: A review of recent data | Q21245059 |
| Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice | Q24306427 | ||
| Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria | Q24318466 | ||
| Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding | Q24656064 | ||
| Fructose consumption as a risk factor for non-alcoholic fatty liver disease | Q24657933 | ||
| Interplay between lipids and branched-chain amino acids in development of insulin resistance | Q26852310 | ||
| Adverse effects of dietary fructose | Q28287841 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase | Q28508079 | ||
| A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism | Q28513195 | ||
| Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export | Q29306550 | ||
| SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | Q29547646 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. | Q33672543 | ||
| High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis | Q34023013 | ||
| A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. | Q34047773 | ||
| Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. | Q34091776 | ||
| Metabolic effects of fructose and the worldwide increase in obesity. | Q34093669 | ||
| Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. | Q34260855 | ||
| A randomized trial of sugar-sweetened beverages and adolescent body weight | Q34301068 | ||
| A trial of sugar-free or sugar-sweetened beverages and body weight in children | Q34301075 | ||
| Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial | Q34375398 | ||
| A causal role for uric acid in fructose-induced metabolic syndrome | Q34460827 | ||
| High glycemic index foods, overeating, and obesity. | Q34502478 | ||
| Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion | Q34532972 | ||
| Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease | Q35115991 | ||
| ChREBP Regulates Itself and Metabolic Genes Implicated in Lipid Accumulation in β-Cell Line | Q35903586 | ||
| The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans | Q36005304 | ||
| The metabolic syndrome: a call to action | Q36351233 | ||
| Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial | Q36477877 | ||
| Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome | Q36531438 | ||
| Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts | Q36787024 | ||
| ChREBP, a transcriptional regulator of glucose and lipid metabolism | Q36788526 | ||
| Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease | Q36818384 | ||
| Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism | Q36829684 | ||
| Long-Term Fructose Intake Increases Adipogenic Potential: Evidence of Direct Effects of Fructose on Adipocyte Precursor Cells | Q36846250 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice | Q37375695 | ||
| ChREBP regulates fructose-induced glucose production independently of insulin signaling | Q37395843 | ||
| A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. | Q37571422 | ||
| Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. | Q38311106 | ||
| Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose | Q39206330 | ||
| Increasing prevalence of the metabolic syndrome among u.s. Adults. | Q40479545 | ||
| Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice | Q41447207 | ||
| High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase | Q41856930 | ||
| Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. | Q41889139 | ||
| Adiponectin resistance and proinflammatory changes in the visceral adipose tissue induced by fructose consumption via ketohexokinase-dependent pathway | Q42199169 | ||
| Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease | Q43714030 | ||
| Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c | Q43848640 | ||
| Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice | Q43943139 | ||
| The global NAFLD epidemic | Q44238213 | ||
| Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study | Q44451078 | ||
| The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). | Q44475268 | ||
| A reduced-glycemic load diet in the treatment of adolescent obesity. | Q44545449 | ||
| Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance | Q44760628 | ||
| A lipidomic analysis of nonalcoholic fatty liver disease. | Q44931121 | ||
| Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake | Q46473255 | ||
| Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction | Q50162855 | ||
| Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. | Q51330295 | ||
| Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. | Q51381196 | ||
| Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. | Q53555710 | ||
| Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver | Q57016669 | ||
| Mechanisms for the acute effect of fructose on postprandial lipemia | Q80447618 | ||
| Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess | Q81222711 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4059-4074 | |
| P577 | publication date | 2017-10-03 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling | |
| P478 | volume | 127 |
| Q52715864 | Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis. |
| Q58594053 | Carbotoxicity-Noxious Effects of Carbohydrates |
| Q102075602 | Cell type-selective secretome profiling in vivo |
| Q54256726 | ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption. |
| Q59789588 | Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD |
| Q98177141 | Determining the contribution of a high-fructose corn syrup formulation to hepatic glycogen synthesis during ad-libitum feeding in mice |
| Q64885974 | Diet-induced β-cell insulin resistance results in reversible loss of functional β-cell mass. |
| Q99630796 | Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health |
| Q92826678 | Dietary Fructose and the Metabolic Syndrome |
| Q90438587 | Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins |
| Q90665321 | Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate |
| Q92933205 | Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress |
| Q50147806 | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. |
| Q49498180 | Fructose metabolism and metabolic disease |
| Q98665244 | Fructose stimulated de novo lipogenesis is promoted by inflammation |
| Q55541493 | Glycerol fructose combined with vitamin B6 is beneficial to postoperative recovery of patients with cerebral aneurysm. |
| Q58700518 | Human hepatic 3D spheroids as a model for steatosis and insulin resistance |
| Q47553435 | Interplay between ChREBP and SREBP-1c Coordinates Postprandial Glycolysis and Lipogenesis in Livers of Mice |
| Q92798647 | Lipometabolism and Glycometabolism in Liver Diseases |
| Q64105214 | Liver proteomics unravel the metabolic pathways related to Feed Efficiency in beef cattle |
| Q64229141 | Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver |
| Q89568436 | Metabolic effects of the dietary monosaccharides fructose, fructose-glucose, or glucose in mice fed a starch-containing moderate high-fat diet |
| Q54977720 | Modulation of hepatic inflammation and energy-sensing pathways in the rat liver by high-fructose diet and chronic stress. |
| Q88446596 | Neuronal Suppressor of Cytokine Signaling 3: Role in Modulating Chronic Metabolic and Cardiovascular Effects of Leptin |
| Q98384632 | Nf1 Heterozygous Mice Recapitulate the Anthropometric and Metabolic Features of Human Neurofibromatosis Type 1 |
| Q55404905 | Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. |
| Q90020289 | Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation |
| Q96774001 | Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue |
| Q90191189 | Serum Amyloid P and a Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin Ligand Inhibit High-Fat Diet-Induced Adipose Tissue and Liver Inflammation and Steatosis in Mice |
| Q64990716 | Similar effects of high-fructose and high-glucose feeding in a Drosophila model of obesity and diabetes. |
| Q60934079 | Temporal dynamics of liver mitochondrial protein acetylation and succinylation and metabolites due to high fat diet and/or excess glucose or fructose |
| Q92850767 | Too Much Sugar-The Not-So-Sweet Reality of Its Impact on Our Health |
| Q91842180 | Vitamin E sequestration by liver fat in humans |
Search more.